Deutsche Bank
AZN icon

Deutsche Bank’s AstraZeneca AZN Stock Holding History

Deutsche Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,046
Closed -$284K – 5128
2014
Q4 		$284K Buy
4,046
+1,109
+38% +$79.4K ﹤0.01% 4093
2014
Q3 		$209K Buy
+2,937
New +$215K ﹤0.01% 4040

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Deutsche Bank's AZN Position: Q1 2026 in Review

Deutsche Bank increased its AstraZeneca (AZN) stake by 4,471% in Q1 2026, buying an estimated $2.29B and bringing the position to 12,129,724 shares worth $2.39B. The position accounts for 0.79% of the portfolio, ranked #15.

Deutsche Bank first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Deutsche Bank held 12,129,724 shares of AstraZeneca worth $2.39B as of Q1 2026.
  • Deutsche Bank bought 11,864,378 AstraZeneca shares in Q1 2026, an estimated $2.29B.
  • AstraZeneca made up 0.79% of Deutsche Bank's portfolio in Q1 2026, its #15 holding.
  • Deutsche Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.